Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Helvepharm is a leading Swiss pharmaceutical company specializing in the development and distribution of high-quality generic medicines. Founded in 1982 and headquartered in Frauenfeld, the company offers a broad portfolio of over 150 products across various therapeutic areas, including cardiovascular, central nervous system, and metabolic diseases. Since its acquisition, it has operated as the Swiss branch of Zentiva, one of Europe's largest generics manufacturers. Helvepharm focuses on providing cost-effective healthcare solutions to the Swiss market, serving pharmacists, physicians, and patients. The company plays a vital role in the Swiss healthcare system by ensuring the supply of essential, affordable medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Helvepharm.